Provider groups oppose MedPAC recommendation for FY 2010 nursing home rate freeze

HHS gives Medicare Advantage plans a $6.7 billion infusion
HHS gives Medicare Advantage plans a $6.7 billion infusion
The Medicare Payment Advisory Commission (MedPAC) recommended to Congress Tuesday that skilled nursing and rehabilitation facilities not receive a reimbursement rate increase for fiscal year 2010. The recommendation angered nursing home providers.

The freeze would "undermine U.S. seniors care needs, jeopardize quality, destabilize the long-term care sector, and [are] directly at odds with the economic stimulus objectives," American Health Care Association President and CEO Bruce Yarwood said.

Alan Rosenbloom, president of the Alliance for Quality Nursing Home Care, said that the recommendation is "seriously flawed," noting that Medicare helps to prop up inadequate Medicaid funding.

Besides freezing skilled nursing facility and rehab facility reimbursement rates, MedPAC recommended slicing 5.5% from home health services in FY 2010. Long-term care hospitals would see a 1.6% reimbursement increase. (McKnight's, 1/12). Congress has declined to follow MedPAC's recommendations in recent years.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.